Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  8/10/2010
University of California at Los Angeles
mi
from
Los Angeles, CA
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 8/10/2010
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  8/10/2010
University of California, San Francisco
mi
from
San Francisco, CA
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 8/10/2010
University of California, San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  8/10/2010
National Jewish Medical and Research Center
mi
from
Denver, CO
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 8/10/2010
National Jewish Medical and Research Center
mi
from
Denver, CO
Click here to add this to my saved trials
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  8/10/2010
University of Chicago
mi
from
Chicago, IL
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 8/10/2010
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  8/10/2010
University of Michigan
mi
from
Ann Arbor, MI
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 8/10/2010
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  8/10/2010
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 8/10/2010
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  8/10/2010
Temple University
mi
from
Philadelphia, PA
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 8/10/2010
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  8/10/2010
Brown University
mi
from
Providence, RI
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 8/10/2010
Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  8/10/2010
Vanderbilt University
mi
from
Nashville, TN
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
COMET: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in IPF. A Prospective, Multi-Center, Longitudinal Follow up Study of Subjects With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 8/10/2010
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
University of California, San Francisco
mi
from
San Francisco, CA
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
University of California, San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
National Jewish Health
mi
from
Denver, CO
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
Georgetown University School of Medicine
mi
from
Washington,
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
Georgetown University School of Medicine
mi
from
Washington,
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
Feinberg School of Medicine, Northwestern University
mi
from
Chicago, IL
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
Feinberg School of Medicine, Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
University of Illinois at Chicago, College of Medicine
mi
from
Chicago, IL
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
University of Illinois at Chicago, College of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
Boston University School of Medicine
mi
from
Boston, MA
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
University of Michigan Medical School
mi
from
Ann Arbor, MI
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
University of Michigan Medical School
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
Medical University of South Carolina
mi
from
Charleston, SC
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
University of Texas Medical School in Houston
mi
from
Houston, TX
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
University of Texas Medical School in Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Transoral Robotic Surgery (TORS) for Sleep Apnea
A Pilot Study Assessing Surgical Exposure During Transoral Robotic Surgery (TORS) for Sleep Apnea Using the da Vinci® Robotic Surgical System (Intuitive Surgical, Inc., Sunnyvale, CA)
Status: Enrolling
Updated:  9/21/2010
Univ of Pennsylvania
mi
from
Philadelphia, PA
Transoral Robotic Surgery (TORS) for Sleep Apnea
A Pilot Study Assessing Surgical Exposure During Transoral Robotic Surgery (TORS) for Sleep Apnea Using the da Vinci® Robotic Surgical System (Intuitive Surgical, Inc., Sunnyvale, CA)
Status: Enrolling
Updated: 9/21/2010
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Assess the Changes in Blood Clotting Factors and Blood Vessel Wall Function in Obstructive Sleep Apnea
Variability of Fibrinolytic Markers and Endothelial Function in Obstructive Sleep Apnea
Status: Enrolling
Updated:  10/18/2010
Vanderbilt University Medical Center,Department of Neurology
mi
from
Nashville, TN
Study to Assess the Changes in Blood Clotting Factors and Blood Vessel Wall Function in Obstructive Sleep Apnea
Variability of Fibrinolytic Markers and Endothelial Function in Obstructive Sleep Apnea
Status: Enrolling
Updated: 10/18/2010
Vanderbilt University Medical Center,Department of Neurology
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Pharmacokinetics Study With AB0024 in Patients With Idiopathic Pulmonary Fibrosis.
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB0024 in Adult Patients With Idiopathic Pulmonary Fibrosis.
Status: Enrolling
Updated:  11/15/2010
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Safety and Pharmacokinetics Study With AB0024 in Patients With Idiopathic Pulmonary Fibrosis.
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB0024 in Adult Patients With Idiopathic Pulmonary Fibrosis.
Status: Enrolling
Updated: 11/15/2010
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Pharmacokinetics Study With AB0024 in Patients With Idiopathic Pulmonary Fibrosis.
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB0024 in Adult Patients With Idiopathic Pulmonary Fibrosis.
Status: Enrolling
Updated:  11/15/2010
Stanford Univ Med Ctr
mi
from
Stanford, CA
Safety and Pharmacokinetics Study With AB0024 in Patients With Idiopathic Pulmonary Fibrosis.
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB0024 in Adult Patients With Idiopathic Pulmonary Fibrosis.
Status: Enrolling
Updated: 11/15/2010
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Safety and Pharmacokinetics Study With AB0024 in Patients With Idiopathic Pulmonary Fibrosis.
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB0024 in Adult Patients With Idiopathic Pulmonary Fibrosis.
Status: Enrolling
Updated:  11/15/2010
UPMC Translational Research Center
mi
from
Pittsburg, PA
Safety and Pharmacokinetics Study With AB0024 in Patients With Idiopathic Pulmonary Fibrosis.
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB0024 in Adult Patients With Idiopathic Pulmonary Fibrosis.
Status: Enrolling
Updated: 11/15/2010
UPMC Translational Research Center
mi
from
Pittsburg, PA
Click here to add this to my saved trials
Safety and Pharmacokinetics Study With AB0024 in Patients With Idiopathic Pulmonary Fibrosis.
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB0024 in Adult Patients With Idiopathic Pulmonary Fibrosis.
Status: Enrolling
Updated:  11/15/2010
Medical University of South Carolina
mi
from
Charleston, SC
Safety and Pharmacokinetics Study With AB0024 in Patients With Idiopathic Pulmonary Fibrosis.
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB0024 in Adult Patients With Idiopathic Pulmonary Fibrosis.
Status: Enrolling
Updated: 11/15/2010
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Safety and Pharmacokinetics Study With AB0024 in Patients With Idiopathic Pulmonary Fibrosis.
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB0024 in Adult Patients With Idiopathic Pulmonary Fibrosis.
Status: Enrolling
Updated:  11/15/2010
Vanderbilt University Medical Center
mi
from
Nashville, TN
Safety and Pharmacokinetics Study With AB0024 in Patients With Idiopathic Pulmonary Fibrosis.
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB0024 in Adult Patients With Idiopathic Pulmonary Fibrosis.
Status: Enrolling
Updated: 11/15/2010
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Anxiety Self-Management for ICU Patients Receiving Mechanical Ventilation
Reducing Sedative Exposure in Ventilated ICU Patients
Status: Enrolling
Updated:  1/13/2011
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Anxiety Self-Management for ICU Patients Receiving Mechanical Ventilation
Reducing Sedative Exposure in Ventilated ICU Patients
Status: Enrolling
Updated: 1/13/2011
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of Yoga as a Therapy for Cystic Fibrosis (CF) Patients
Yoga as a Therapy for Adolescents and Young Adults With Cystic Fibrosis: A Pilot Study
Status: Enrolling
Updated:  3/28/2011
Seattle Children's Hospital
mi
from
Seattle, WA
Study of Yoga as a Therapy for Cystic Fibrosis (CF) Patients
Yoga as a Therapy for Adolescents and Young Adults With Cystic Fibrosis: A Pilot Study
Status: Enrolling
Updated: 3/28/2011
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Abstinence-Linked Money Management Multisite
Abstinence-Linked Money Management Multisite
Status: Enrolling
Updated:  3/31/2011
Greater Bridgeport Mental Health Center
mi
from
Bridgeport, CT
Abstinence-Linked Money Management Multisite
Abstinence-Linked Money Management Multisite
Status: Enrolling
Updated: 3/31/2011
Greater Bridgeport Mental Health Center
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Abstinence-Linked Money Management Multisite
Abstinence-Linked Money Management Multisite
Status: Enrolling
Updated:  3/31/2011
Capitol Region Mental Health Center
mi
from
Hartford, CT
Abstinence-Linked Money Management Multisite
Abstinence-Linked Money Management Multisite
Status: Enrolling
Updated: 3/31/2011
Capitol Region Mental Health Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Mucus Dehydration and Evolution of Chronic Obstructive Pulmonary Disease (COPD) Lung Disease
Mucus Dehydration and Evolution of COPD Lung Disease
Status: Enrolling
Updated:  4/25/2011
University of North Carolina Chapel Hill
mi
from
Chapel Hill, NC
Mucus Dehydration and Evolution of Chronic Obstructive Pulmonary Disease (COPD) Lung Disease
Mucus Dehydration and Evolution of COPD Lung Disease
Status: Enrolling
Updated: 4/25/2011
University of North Carolina Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED
Assessment of the Utility of Vibration Response Imaging (VRI) in Evaluating Dyspnea Patients Presenting to the Emergency Department
Status: Enrolling
Updated:  5/12/2011
Christiana Care Health System
mi
from
Newark, DE
Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED
Assessment of the Utility of Vibration Response Imaging (VRI) in Evaluating Dyspnea Patients Presenting to the Emergency Department
Status: Enrolling
Updated: 5/12/2011
Christiana Care Health System
mi
from
Newark, DE
Click here to add this to my saved trials
Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED
Assessment of the Utility of Vibration Response Imaging (VRI) in Evaluating Dyspnea Patients Presenting to the Emergency Department
Status: Enrolling
Updated:  5/12/2011
University of Nevada School of Medicine
mi
from
Las Vegas, NV
Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED
Assessment of the Utility of Vibration Response Imaging (VRI) in Evaluating Dyspnea Patients Presenting to the Emergency Department
Status: Enrolling
Updated: 5/12/2011
University of Nevada School of Medicine
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED
Assessment of the Utility of Vibration Response Imaging (VRI) in Evaluating Dyspnea Patients Presenting to the Emergency Department
Status: Enrolling
Updated:  5/12/2011
Lincoln Medical & Mental Health Center
mi
from
Bronx, NY
Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED
Assessment of the Utility of Vibration Response Imaging (VRI) in Evaluating Dyspnea Patients Presenting to the Emergency Department
Status: Enrolling
Updated: 5/12/2011
Lincoln Medical & Mental Health Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED
Assessment of the Utility of Vibration Response Imaging (VRI) in Evaluating Dyspnea Patients Presenting to the Emergency Department
Status: Enrolling
Updated:  5/12/2011
Mount Sinai School of Medicine
mi
from
New York, NY
Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED
Assessment of the Utility of Vibration Response Imaging (VRI) in Evaluating Dyspnea Patients Presenting to the Emergency Department
Status: Enrolling
Updated: 5/12/2011
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED
Assessment of the Utility of Vibration Response Imaging (VRI) in Evaluating Dyspnea Patients Presenting to the Emergency Department
Status: Enrolling
Updated:  5/12/2011
MetroHealth Med Ctr
mi
from
Cleveland, OH
Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED
Assessment of the Utility of Vibration Response Imaging (VRI) in Evaluating Dyspnea Patients Presenting to the Emergency Department
Status: Enrolling
Updated: 5/12/2011
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED
Assessment of the Utility of Vibration Response Imaging (VRI) in Evaluating Dyspnea Patients Presenting to the Emergency Department
Status: Enrolling
Updated:  5/12/2011
Pennsylvania Hospital
mi
from
Philadelphia, PA
Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED
Assessment of the Utility of Vibration Response Imaging (VRI) in Evaluating Dyspnea Patients Presenting to the Emergency Department
Status: Enrolling
Updated: 5/12/2011
Pennsylvania Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED
Assessment of the Utility of Vibration Response Imaging (VRI) in Evaluating Dyspnea Patients Presenting to the Emergency Department
Status: Enrolling
Updated:  5/12/2011
Baylor College of Medicine
mi
from
Houston, TX
Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED
Assessment of the Utility of Vibration Response Imaging (VRI) in Evaluating Dyspnea Patients Presenting to the Emergency Department
Status: Enrolling
Updated: 5/12/2011
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
High Flow Therapy (HFT) to Treat Respiratory Insufficiency in Chronic Obstructive Pulmonary Disease (COPD)
Vapotherm High Flow Therapy Via Nasal Cannula to Treat Respiratory Insufficiency in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  6/6/2011
Temple University Hospital
mi
from
Philadelphia, PA
High Flow Therapy (HFT) to Treat Respiratory Insufficiency in Chronic Obstructive Pulmonary Disease (COPD)
Vapotherm High Flow Therapy Via Nasal Cannula to Treat Respiratory Insufficiency in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 6/6/2011
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease: A Prospective Cohort Study
Status: Enrolling
Updated:  6/7/2011
John Muir Health
mi
from
Concord, CA
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease: A Prospective Cohort Study
Status: Enrolling
Updated: 6/7/2011
John Muir Health
mi
from
Concord, CA
Click here to add this to my saved trials
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease: A Prospective Cohort Study
Status: Enrolling
Updated:  6/7/2011
Seton Pulmonary & Cardiac Rehabilitation
mi
from
Daly City, CA
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease: A Prospective Cohort Study
Status: Enrolling
Updated: 6/7/2011
Seton Pulmonary & Cardiac Rehabilitation
mi
from
Daly City, CA
Click here to add this to my saved trials
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease: A Prospective Cohort Study
Status: Enrolling
Updated:  6/7/2011
Yale University School of Medicine
mi
from
New Haven, CT
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease: A Prospective Cohort Study
Status: Enrolling
Updated: 6/7/2011
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease: A Prospective Cohort Study
Status: Enrolling
Updated:  6/7/2011
Duke Univ Med Ctr
mi
from
Durham, NC
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease: A Prospective Cohort Study
Status: Enrolling
Updated: 6/7/2011
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease: A Prospective Cohort Study
Status: Enrolling
Updated:  6/7/2011
Inova Fairfax Hospital
mi
from
Falls Church, VA
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease: A Prospective Cohort Study
Status: Enrolling
Updated: 6/7/2011
Inova Fairfax Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials
Wheezometer™ Exploratory (WM) Field Study
Wheezometer™ Exploratory (WM) Field Study
Status: Enrolling
Updated:  6/8/2011
California Allergy and Asthma Medical Group, Inc.
mi
from
Los Angeles, CA
Wheezometer™ Exploratory (WM) Field Study
Wheezometer™ Exploratory (WM) Field Study
Status: Enrolling
Updated: 6/8/2011
California Allergy and Asthma Medical Group, Inc.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100)
A Phase 2a, Ascending Dose, Placebo-Controlled Study to Evaluate the Safety of CTX-100 (Formerly ETX-100) Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  6/16/2011
Arizona Research Associates
mi
from
Tucson, AZ
Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100)
A Phase 2a, Ascending Dose, Placebo-Controlled Study to Evaluate the Safety of CTX-100 (Formerly ETX-100) Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 6/16/2011
Arizona Research Associates
mi
from
Tucson, AZ
Click here to add this to my saved trials
Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100)
A Phase 2a, Ascending Dose, Placebo-Controlled Study to Evaluate the Safety of CTX-100 (Formerly ETX-100) Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  6/16/2011
VA Harbor Medical Center
mi
from
New York, NY
Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100)
A Phase 2a, Ascending Dose, Placebo-Controlled Study to Evaluate the Safety of CTX-100 (Formerly ETX-100) Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 6/16/2011
VA Harbor Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100)
A Phase 2a, Ascending Dose, Placebo-Controlled Study to Evaluate the Safety of CTX-100 (Formerly ETX-100) Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  6/16/2011
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100)
A Phase 2a, Ascending Dose, Placebo-Controlled Study to Evaluate the Safety of CTX-100 (Formerly ETX-100) Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 6/16/2011
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials